erbb2 oncogene  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc erbb2 oncogene
    <t>ERBB2</t> and RAS protein levels were assessed by Western blots using antibodies against H-RAS or ERBB2 for total cell lysates prepared from prostate cancer cells transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Blots with antibodies against actin served as loading controls. Numbers in white represent fold changes in ERBB2 or RAS protein levels in ERBB2 - or RAS -overexpressing cells relative to those in their corresponding PBP control cells after the actin normalization.
    Erbb2 Oncogene, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/erbb2 oncogene/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    erbb2 oncogene - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells"

    Article Title: ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0099525

    ERBB2 and RAS protein levels were assessed by Western blots using antibodies against H-RAS or ERBB2 for total cell lysates prepared from prostate cancer cells transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Blots with antibodies against actin served as loading controls. Numbers in white represent fold changes in ERBB2 or RAS protein levels in ERBB2 - or RAS -overexpressing cells relative to those in their corresponding PBP control cells after the actin normalization.
    Figure Legend Snippet: ERBB2 and RAS protein levels were assessed by Western blots using antibodies against H-RAS or ERBB2 for total cell lysates prepared from prostate cancer cells transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Blots with antibodies against actin served as loading controls. Numbers in white represent fold changes in ERBB2 or RAS protein levels in ERBB2 - or RAS -overexpressing cells relative to those in their corresponding PBP control cells after the actin normalization.

    Techniques Used: Western Blot, Transfection

    Cell growth rates were assessed by cell counting every 12 hours or 24 hours for various prostate cancer cells that were transfected with control retroviruses ( PBP ), or retroviruses overexpressing either PBP-H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ).
    Figure Legend Snippet: Cell growth rates were assessed by cell counting every 12 hours or 24 hours for various prostate cancer cells that were transfected with control retroviruses ( PBP ), or retroviruses overexpressing either PBP-H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ).

    Techniques Used: Cell Counting, Transfection

    Cell migration rates were estimated by a wound healing assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Left panels showed percentages of wounds remained at different time points. The percentages of wounds were estimated based on the average of 12 measurements on each plate reflecting measurements of four evenly distributed sections on each of the three wounds/scratches on each plate. Data were presented as means ± SD from three replicates. Right panels showed representative images taken at different time points. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.
    Figure Legend Snippet: Cell migration rates were estimated by a wound healing assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Left panels showed percentages of wounds remained at different time points. The percentages of wounds were estimated based on the average of 12 measurements on each plate reflecting measurements of four evenly distributed sections on each of the three wounds/scratches on each plate. Data were presented as means ± SD from three replicates. Right panels showed representative images taken at different time points. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.

    Techniques Used: Migration, Wound Healing Assay, Transfection

    Cell motilities were assessed by a transwell-based motility assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Each bar graph showed the relative numbers of cells that have passed through the transwell inserts/membranes, which were stained and counted under a microscope for at least 10 fields per insert. Data were presented as means ± SD from three replicates. Representative images taken at a given time point were shown underneath each bar graph. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.
    Figure Legend Snippet: Cell motilities were assessed by a transwell-based motility assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Each bar graph showed the relative numbers of cells that have passed through the transwell inserts/membranes, which were stained and counted under a microscope for at least 10 fields per insert. Data were presented as means ± SD from three replicates. Representative images taken at a given time point were shown underneath each bar graph. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.

    Techniques Used: Motility Assay, Transfection, Staining, Microscopy

    Cell invasiveness was assessed by a transwell-based invasion assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Each bar graph showed the numbers of cells that have passed through the collagen matrix either 72 hours (for PC3 cells) or 96 hours (for DU145 cells) after plating. Transwell inserts were stained and invading cells were counted for the entire inserts. Data were presented as means ± SD from three replicates. Representative images were shown underneath each bar graph. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.
    Figure Legend Snippet: Cell invasiveness was assessed by a transwell-based invasion assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Each bar graph showed the numbers of cells that have passed through the collagen matrix either 72 hours (for PC3 cells) or 96 hours (for DU145 cells) after plating. Transwell inserts were stained and invading cells were counted for the entire inserts. Data were presented as means ± SD from three replicates. Representative images were shown underneath each bar graph. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.

    Techniques Used: Transwell Invasion Assay, Transfection, Staining

    (A) Senescence-associated β-galactosidase activities were assessed by X-gal staining for human prostate cancer cell lines transfected with either control retroviruses ( PBP ) or retroviruses overexpressing PBP-H-RAS ( RAS ). PC3 cells expressing an extremely high level of RAS ( Hi-RAS ) were included for comparisons. Senescent BJ human skin fibroblast cells were used as a positive control for X-gal staining. Representative images were shown with representative X-gal-positive cells being marked with red arrows. Inserts in each image showed magnified, representative X-gal-positive cells. ( B ) Quantifications of data collected from panel ( A ). Data were presented as means ± SD from three replicates. ( C ) RAS protein levels assessed by Western blot analysis with antibodies against H-RAS for parental PC3 cells (P), PC3 cells transfected with control retroviruses ( PBP ), or PC3 cells transfected with the PBP-H-RAS retroviruses overexpressing a moderate level of RAS ( RAS ) or a much higher level of RAS ( Hi-RAS ). A blot using antibodies against actin was used as a loading control. Numbers in white represent RAS protein levels in fold changes in ERBB2 - or RAS -overexpressing cells relative to those in PBP control cells after the actin normalization. Scare bar: 100 µM.
    Figure Legend Snippet: (A) Senescence-associated β-galactosidase activities were assessed by X-gal staining for human prostate cancer cell lines transfected with either control retroviruses ( PBP ) or retroviruses overexpressing PBP-H-RAS ( RAS ). PC3 cells expressing an extremely high level of RAS ( Hi-RAS ) were included for comparisons. Senescent BJ human skin fibroblast cells were used as a positive control for X-gal staining. Representative images were shown with representative X-gal-positive cells being marked with red arrows. Inserts in each image showed magnified, representative X-gal-positive cells. ( B ) Quantifications of data collected from panel ( A ). Data were presented as means ± SD from three replicates. ( C ) RAS protein levels assessed by Western blot analysis with antibodies against H-RAS for parental PC3 cells (P), PC3 cells transfected with control retroviruses ( PBP ), or PC3 cells transfected with the PBP-H-RAS retroviruses overexpressing a moderate level of RAS ( RAS ) or a much higher level of RAS ( Hi-RAS ). A blot using antibodies against actin was used as a loading control. Numbers in white represent RAS protein levels in fold changes in ERBB2 - or RAS -overexpressing cells relative to those in PBP control cells after the actin normalization. Scare bar: 100 µM.

    Techniques Used: Staining, Transfection, Expressing, Positive Control, Western Blot

    Protein levels for various kinases and their phosphorylated forms were assessed by Western blot analyses for parental prostate cancer cells that were transfected either with control retroviruses ( PBP ), or with retroviruses overexpressing PBP-H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Actin was used as a loading control. Numbers in white represent protein levels in fold changes relative to those in PBP control cells after the actin normalization.
    Figure Legend Snippet: Protein levels for various kinases and their phosphorylated forms were assessed by Western blot analyses for parental prostate cancer cells that were transfected either with control retroviruses ( PBP ), or with retroviruses overexpressing PBP-H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Actin was used as a loading control. Numbers in white represent protein levels in fold changes relative to those in PBP control cells after the actin normalization.

    Techniques Used: Western Blot, Transfection

    oncogenic receptor erbb2  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc oncogenic receptor erbb2
    Oncogenic Receptor Erbb2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/oncogenic receptor erbb2/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    oncogenic receptor erbb2 - by Bioz Stars, 2023-03
    86/100 stars

    Images

    oncogenic receptor erbb2  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc oncogenic receptor erbb2
    Oncogenic Receptor Erbb2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/oncogenic receptor erbb2/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    oncogenic receptor erbb2 - by Bioz Stars, 2023-03
    86/100 stars

    Images

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    Cell Signaling Technology Inc erbb2 oncogene
    <t>ERBB2</t> and RAS protein levels were assessed by Western blots using antibodies against H-RAS or ERBB2 for total cell lysates prepared from prostate cancer cells transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Blots with antibodies against actin served as loading controls. Numbers in white represent fold changes in ERBB2 or RAS protein levels in ERBB2 - or RAS -overexpressing cells relative to those in their corresponding PBP control cells after the actin normalization.
    Erbb2 Oncogene, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/erbb2 oncogene/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    erbb2 oncogene - by Bioz Stars, 2023-03
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc oncogenic receptor erbb2
    <t>ERBB2</t> and RAS protein levels were assessed by Western blots using antibodies against H-RAS or ERBB2 for total cell lysates prepared from prostate cancer cells transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Blots with antibodies against actin served as loading controls. Numbers in white represent fold changes in ERBB2 or RAS protein levels in ERBB2 - or RAS -overexpressing cells relative to those in their corresponding PBP control cells after the actin normalization.
    Oncogenic Receptor Erbb2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/oncogenic receptor erbb2/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    oncogenic receptor erbb2 - by Bioz Stars, 2023-03
    86/100 stars
      Buy from Supplier

    Image Search Results


    ERBB2 and RAS protein levels were assessed by Western blots using antibodies against H-RAS or ERBB2 for total cell lysates prepared from prostate cancer cells transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Blots with antibodies against actin served as loading controls. Numbers in white represent fold changes in ERBB2 or RAS protein levels in ERBB2 - or RAS -overexpressing cells relative to those in their corresponding PBP control cells after the actin normalization.

    Journal: PLoS ONE

    Article Title: ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

    doi: 10.1371/journal.pone.0099525

    Figure Lengend Snippet: ERBB2 and RAS protein levels were assessed by Western blots using antibodies against H-RAS or ERBB2 for total cell lysates prepared from prostate cancer cells transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Blots with antibodies against actin served as loading controls. Numbers in white represent fold changes in ERBB2 or RAS protein levels in ERBB2 - or RAS -overexpressing cells relative to those in their corresponding PBP control cells after the actin normalization.

    Article Snippet: Cell signaling pathways activated by the ERBB2 oncogene or the RAS oncogene are frequently found to be altered in metastatic prostate cancers.

    Techniques: Western Blot, Transfection

    Cell growth rates were assessed by cell counting every 12 hours or 24 hours for various prostate cancer cells that were transfected with control retroviruses ( PBP ), or retroviruses overexpressing either PBP-H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ).

    Journal: PLoS ONE

    Article Title: ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

    doi: 10.1371/journal.pone.0099525

    Figure Lengend Snippet: Cell growth rates were assessed by cell counting every 12 hours or 24 hours for various prostate cancer cells that were transfected with control retroviruses ( PBP ), or retroviruses overexpressing either PBP-H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ).

    Article Snippet: Cell signaling pathways activated by the ERBB2 oncogene or the RAS oncogene are frequently found to be altered in metastatic prostate cancers.

    Techniques: Cell Counting, Transfection

    Cell migration rates were estimated by a wound healing assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Left panels showed percentages of wounds remained at different time points. The percentages of wounds were estimated based on the average of 12 measurements on each plate reflecting measurements of four evenly distributed sections on each of the three wounds/scratches on each plate. Data were presented as means ± SD from three replicates. Right panels showed representative images taken at different time points. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.

    Journal: PLoS ONE

    Article Title: ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

    doi: 10.1371/journal.pone.0099525

    Figure Lengend Snippet: Cell migration rates were estimated by a wound healing assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Left panels showed percentages of wounds remained at different time points. The percentages of wounds were estimated based on the average of 12 measurements on each plate reflecting measurements of four evenly distributed sections on each of the three wounds/scratches on each plate. Data were presented as means ± SD from three replicates. Right panels showed representative images taken at different time points. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.

    Article Snippet: Cell signaling pathways activated by the ERBB2 oncogene or the RAS oncogene are frequently found to be altered in metastatic prostate cancers.

    Techniques: Migration, Wound Healing Assay, Transfection

    Cell motilities were assessed by a transwell-based motility assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Each bar graph showed the relative numbers of cells that have passed through the transwell inserts/membranes, which were stained and counted under a microscope for at least 10 fields per insert. Data were presented as means ± SD from three replicates. Representative images taken at a given time point were shown underneath each bar graph. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.

    Journal: PLoS ONE

    Article Title: ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

    doi: 10.1371/journal.pone.0099525

    Figure Lengend Snippet: Cell motilities were assessed by a transwell-based motility assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Each bar graph showed the relative numbers of cells that have passed through the transwell inserts/membranes, which were stained and counted under a microscope for at least 10 fields per insert. Data were presented as means ± SD from three replicates. Representative images taken at a given time point were shown underneath each bar graph. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.

    Article Snippet: Cell signaling pathways activated by the ERBB2 oncogene or the RAS oncogene are frequently found to be altered in metastatic prostate cancers.

    Techniques: Motility Assay, Transfection, Staining, Microscopy

    Cell invasiveness was assessed by a transwell-based invasion assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Each bar graph showed the numbers of cells that have passed through the collagen matrix either 72 hours (for PC3 cells) or 96 hours (for DU145 cells) after plating. Transwell inserts were stained and invading cells were counted for the entire inserts. Data were presented as means ± SD from three replicates. Representative images were shown underneath each bar graph. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.

    Journal: PLoS ONE

    Article Title: ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

    doi: 10.1371/journal.pone.0099525

    Figure Lengend Snippet: Cell invasiveness was assessed by a transwell-based invasion assay for prostate cancer cells that were transfected with either control retroviruses ( PBP ), or retroviruses overexpressing PBP - H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Each bar graph showed the numbers of cells that have passed through the collagen matrix either 72 hours (for PC3 cells) or 96 hours (for DU145 cells) after plating. Transwell inserts were stained and invading cells were counted for the entire inserts. Data were presented as means ± SD from three replicates. Representative images were shown underneath each bar graph. All images were taken at the same scale with a scale bar of 200 µM displayed in the first image.

    Article Snippet: Cell signaling pathways activated by the ERBB2 oncogene or the RAS oncogene are frequently found to be altered in metastatic prostate cancers.

    Techniques: Transwell Invasion Assay, Transfection, Staining

    (A) Senescence-associated β-galactosidase activities were assessed by X-gal staining for human prostate cancer cell lines transfected with either control retroviruses ( PBP ) or retroviruses overexpressing PBP-H-RAS ( RAS ). PC3 cells expressing an extremely high level of RAS ( Hi-RAS ) were included for comparisons. Senescent BJ human skin fibroblast cells were used as a positive control for X-gal staining. Representative images were shown with representative X-gal-positive cells being marked with red arrows. Inserts in each image showed magnified, representative X-gal-positive cells. ( B ) Quantifications of data collected from panel ( A ). Data were presented as means ± SD from three replicates. ( C ) RAS protein levels assessed by Western blot analysis with antibodies against H-RAS for parental PC3 cells (P), PC3 cells transfected with control retroviruses ( PBP ), or PC3 cells transfected with the PBP-H-RAS retroviruses overexpressing a moderate level of RAS ( RAS ) or a much higher level of RAS ( Hi-RAS ). A blot using antibodies against actin was used as a loading control. Numbers in white represent RAS protein levels in fold changes in ERBB2 - or RAS -overexpressing cells relative to those in PBP control cells after the actin normalization. Scare bar: 100 µM.

    Journal: PLoS ONE

    Article Title: ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

    doi: 10.1371/journal.pone.0099525

    Figure Lengend Snippet: (A) Senescence-associated β-galactosidase activities were assessed by X-gal staining for human prostate cancer cell lines transfected with either control retroviruses ( PBP ) or retroviruses overexpressing PBP-H-RAS ( RAS ). PC3 cells expressing an extremely high level of RAS ( Hi-RAS ) were included for comparisons. Senescent BJ human skin fibroblast cells were used as a positive control for X-gal staining. Representative images were shown with representative X-gal-positive cells being marked with red arrows. Inserts in each image showed magnified, representative X-gal-positive cells. ( B ) Quantifications of data collected from panel ( A ). Data were presented as means ± SD from three replicates. ( C ) RAS protein levels assessed by Western blot analysis with antibodies against H-RAS for parental PC3 cells (P), PC3 cells transfected with control retroviruses ( PBP ), or PC3 cells transfected with the PBP-H-RAS retroviruses overexpressing a moderate level of RAS ( RAS ) or a much higher level of RAS ( Hi-RAS ). A blot using antibodies against actin was used as a loading control. Numbers in white represent RAS protein levels in fold changes in ERBB2 - or RAS -overexpressing cells relative to those in PBP control cells after the actin normalization. Scare bar: 100 µM.

    Article Snippet: Cell signaling pathways activated by the ERBB2 oncogene or the RAS oncogene are frequently found to be altered in metastatic prostate cancers.

    Techniques: Staining, Transfection, Expressing, Positive Control, Western Blot

    Protein levels for various kinases and their phosphorylated forms were assessed by Western blot analyses for parental prostate cancer cells that were transfected either with control retroviruses ( PBP ), or with retroviruses overexpressing PBP-H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Actin was used as a loading control. Numbers in white represent protein levels in fold changes relative to those in PBP control cells after the actin normalization.

    Journal: PLoS ONE

    Article Title: ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

    doi: 10.1371/journal.pone.0099525

    Figure Lengend Snippet: Protein levels for various kinases and their phosphorylated forms were assessed by Western blot analyses for parental prostate cancer cells that were transfected either with control retroviruses ( PBP ), or with retroviruses overexpressing PBP-H-RAS ( RAS ) or PBP-ERBB2 ( ERBB2 ). Actin was used as a loading control. Numbers in white represent protein levels in fold changes relative to those in PBP control cells after the actin normalization.

    Article Snippet: Cell signaling pathways activated by the ERBB2 oncogene or the RAS oncogene are frequently found to be altered in metastatic prostate cancers.

    Techniques: Western Blot, Transfection